Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Biotech
Fierce Biotech's top 10 most-read stories of 2024
Large-scale site shutdowns, workforce reductions and pipeline reorganizations dominate the list.
Gabrielle Masson
Dec 23, 2024 3:00am
SandboxAQ raises more than $300M for 'next wave of AI'
Dec 18, 2024 2:00pm
Pfizer taps replacement for long-time R&D leader Dolsten
Nov 20, 2024 10:25am
Gilead to lay off 72 staffers, shutter Seattle R&D office
Nov 14, 2024 1:09pm
Ring calls on Singapore research agencies for gene therapy pact
Nov 6, 2024 9:59am
Kymera pivots to immunology, seeks partners for cancer assets
Nov 1, 2024 11:46am
